Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics

Clinical trial NCT03091543 · COMPLETED

Trial details

NCT number: NCT03091543
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2004-05-04
Primary completion: 2004-07-23
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.